Registry of Lobbyists

Advanced Registry Search Results

Registration (25)
Results: 1-25 | Export
  1. Vertex Pharmaceuticals (Canada) Incorporated
    Type: In-house Corporation
    Responsible officer: Michael Siauw, General Manager – Canada
    Registration: 6 of 6 (2023-08-15 to present)
    Posted: 2024-02-01
    Subject matter details: 6
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 5
  2. Vertex Pharmaceuticals (Canada) Inc.
    Type: Consultant
    Lobbyist: Johanne Chambers, 3Sixty Public Affairs Inc.
    Registration: 1 of 1 (2023-07-04 to present)
    Posted: 2023-07-04
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 3
    Government funding: No
  3. Vertex Pharmaceuticals (Canada) Inc.
    Type: Consultant
    Lobbyist: Philip Delistoyanov, 3Sixty Public Affairs
    Registration: 1 of 1 (2023-06-13 to present)
    Posted: 2023-06-13
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 3
    Government funding: No
  4. Vertex Pharmaceuticals (Canada) Incorporated
    Type: In-house Corporation
    Responsible officer: Michael Siauw, General Manager – Canada
    Registration: 5 of 6 (2023-05-01 to 2023-08-15)
    Posted: 2023-05-11
    Subject matter details: 6
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  5. Vertex Pharmaceuticals (Canada) Inc.
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 8 of 8 (2022-11-17 to present)
    Posted: 2022-11-17
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 3
    Government funding: No
  6. Vertex Pharmaceuticals (Canada) Inc.
    Type: Consultant
    Lobbyist: Stephanie Levee, 3Sixty Public Affairs Inc.
    Registration: 4 of 4 (2022-11-11 to present)
    Posted: 2022-11-17
    Subject matter details: 8
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  7. Vertex Pharmaceuticals (Canada) Inc.
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 7 of 8 (2022-07-16 to 2022-11-17)
    Posted: 2022-07-18
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 3
    Government funding: No
  8. Vertex Pharmaceuticals (Canada) Inc.
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 6 of 8 (2022-02-01 to 2022-07-16)
    Posted: 2022-02-01
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 3
    Government funding: No
  9. Vertex Pharmaceuticals (Canada) Incorporated
    Type: In-house Corporation
    Responsible officer: Michael Siauw, General Manager – Canada
    Registration: 4 of 6 (2021-11-19 to 2023-05-01)
    Posted: 2021-12-01
    Subject matter details: 6
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 5
  10. Vertex Pharmaceuticals (Canada) Inc.
    Type: Consultant
    Lobbyist: Stephanie Levee, 3Sixty Public Affairs Inc.
    Registration: 3 of 4 (2021-10-18 to 2022-11-11)
    Posted: 2021-10-20
    Subject matter details: 8
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  11. Vertex Pharmaceuticals (Canada) Inc.
    Type: Consultant
    Lobbyist: Stephanie Levee, 3Sixty Public Affairs Inc.
    Registration: 2 of 4 (2021-05-10 to 2021-10-18)
    Posted: 2021-05-11
    Subject matter details: 8
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  12. Vertex Pharmaceuticals (Canada) Incorporated
    Type: In-house Corporation
    Responsible officer: Michael Siauw, General Manager – Canada
    Registration: 3 of 6 (2021-04-05 to 2021-11-19)
    Posted: 2021-05-03
    Subject matter details: 6
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 5
  13. Vertex Pharmaceuticals (Canada) Inc.
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 5 of 8 (2021-03-31 to 2022-02-01)
    Posted: 2021-04-01
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 3
    Government funding: No
  14. Vertex Pharmaceuticals (Canada) Inc.
    Type: Consultant
    Lobbyist: Stephanie Levee, 3Sixty Public Affairs Inc.
    Registration: 1 of 4 (2020-10-05 to 2021-04-16)
    Posted: 2020-10-05
    Subject matter details: 8
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  15. Vertex Pharmaceuticals (Canada) Inc.
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 4 of 8 (2020-09-30 to 2021-03-31)
    Posted: 2020-09-30
    Subject matter details: 8
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  16. Vertex Pharmaceuticals (Canada) Incorporated
    Type: In-house Corporation
    Responsible officer: Michael Siauw, General Manager – Canada
    Registration: 2 of 6 (2020-07-10 to 2021-04-05)
    Posted: 2020-07-10
    Subject matter details: 6
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 3
  17. Vertex Pharmaceuticals (Canada) Incorporated
    Type: In-house Corporation
    Responsible officer: Michael Siauw, Michael Siauw
    Registration: 1 of 6 (2020-03-18 to 2020-07-10)
    Posted: 2020-03-20
    Subject matter details: 6
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  18. Vertex Pharmaceuticals (Canada) Inc.
    Type: Consultant
    Lobbyist: Valérie Chamula Pellerin, Citoyen Relations SEC
    Registration: 1 of 1 (2020-01-13 to 2020-07-16)
    Posted: 2020-01-16
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  19. Vertex Pharmaceuticals (Canada) Inc.
    Type: Consultant
    Lobbyist: Rachael Manion, 3Sixty Public Affairs
    Registration: 1 of 1 (2018-10-10 to 2019-08-28)
    Posted: 2018-10-10
    Subject matter details: 8
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  20. Vertex Pharmaceuticals (Canada) Inc.
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 3 of 8 (2018-06-15 to 2020-09-30)
    Posted: 2018-06-18
    Subject matter details: 8
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  21. Vertex Pharmaceuticals (Canada) Inc.
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 2 of 8 (2018-02-08 to 2018-06-15)
    Posted: 2018-02-08
    Subject matter details: 7
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  22. Vertex Pharmaceuticals (Canada) Inc.
    Type: Consultant
    Lobbyist: Ludmilla von Hoyningen Huene, 3Sixty Public Affairs
    Registration: 2 of 2 (2017-01-17 to 2017-01-30)
    Posted: 2017-01-20
    Subject matter details: 5
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  23. Vertex Pharmaceuticals (Canada) Inc.
    Type: Consultant
    Lobbyist: Louis-Alexandre Lanthier, Summa Strategies Inc.
    Registration: 1 of 1 (2016-11-07 to 2017-03-28)
    Posted: 2016-11-08
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  24. Vertex Pharmaceuticals (Canada) Inc.
    Type: Consultant
    Lobbyist: Ludmilla von Hoyningen Huene, 3Sixty Public Affairs
    Registration: 1 of 2 (2016-07-08 to 2016-12-31)
    Posted: 2016-07-21
    Subject matter details: 5
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  25. Vertex Pharmaceuticals (Canada) Inc.
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 1 of 8 (2016-02-06 to 2017-03-27)
    Posted: 2016-02-11
    Subject matter details: 5
    Government institutions: 8
    Communication techniques: 2
    Government funding: No

Date Modified: